{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:48:51Z","timestamp":1792064931425,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-52612-6","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:34:18Z","timestamp":1784082858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neopterin, tryptophan and kynurenine as biomarkers in glioblastoma"],"prefix":"10.1038","volume":"16","author":[{"given":"Petr","family":"Krupa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka Kujovska","family":"Krcmova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Krupova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Matousov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Paulikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Kasparova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bohuslav","family":"Melichar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Cesak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"52612_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10689-013-9607-1","volume":"12","author":"K Zhang","year":"2013","unstructured":"Zhang, K., Wang, X. Q., Zhou, B. & Zhang, L. The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: A meta-analysis. Fam. Cancer 12, 449\u2013458. https:\/\/doi.org\/10.1007\/s10689-013-9607-1 (2013).","journal-title":"Fam. Cancer"},{"key":"52612_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-019-0817-0","volume":"7","author":"A Christians","year":"2019","unstructured":"Christians, A. et al. The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas. Acta Neuropathol. Commun. 7, 1\u201311 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"52612_CR3","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00432-021-03536-3","volume":"147","author":"B Powter","year":"2021","unstructured":"Powter, B. et al. Human TERT promoter mutations as a prognostic biomarker in glioma. J. Cancer Res. Clin. Oncol. 147, 1007\u20131017. https:\/\/doi.org\/10.1007\/s00432-021-03536-3 (2021).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"52612_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2147\/ott.S155160","volume":"11","author":"J Li","year":"2018","unstructured":"Li, J., Liang, R., Song, C., Xiang, Y. & Liu, Y. Prognostic significance of epidermal growth factor receptor expression in glioma patients. OncoTargets Ther. 11, 731\u2013742. https:\/\/doi.org\/10.2147\/ott.S155160 (2018).","journal-title":"OncoTargets Ther."},{"key":"52612_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.coi.2021.03.005","volume":"70","author":"M Platten","year":"2021","unstructured":"Platten, M., Friedrich, M., Wainwright, D. A., Panitz, V. & Opitz, C. A. Tryptophan metabolism in brain tumors\u2014IDO and beyond. Curr Opin Immunol 70, 57\u201366. https:\/\/doi.org\/10.1016\/j.coi.2021.03.005 (2021).","journal-title":"Curr Opin Immunol"},{"key":"52612_CR6","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/ni1003","volume":"4","author":"F Fallarino","year":"2003","unstructured":"Fallarino, F. et al. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4, 1206\u20131212. https:\/\/doi.org\/10.1038\/ni1003 (2003).","journal-title":"Nat. Immunol."},{"key":"52612_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/s0304-3940(01)02242-x","volume":"313","author":"S Erhardt","year":"2001","unstructured":"Erhardt, S. et al. Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci. Lett. 313, 96\u201398. https:\/\/doi.org\/10.1016\/s0304-3940(01)02242-x (2001).","journal-title":"Neurosci. Lett."},{"key":"52612_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.psyneuen.2014.11.015","volume":"52","author":"J Savitz","year":"2015","unstructured":"Savitz, J. et al. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology 52, 200\u2013211. https:\/\/doi.org\/10.1016\/j.psyneuen.2014.11.015 (2015).","journal-title":"Psychoneuroendocrinology"},{"key":"52612_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s007020200014","volume":"109","author":"B Widner","year":"2002","unstructured":"Widner, B., Leblhuber, F. & Fuchs, D. Increased neopterin production and tryptophan degradation in advanced Parkinson\u2019s disease. J. Neural Trans. 109, 181\u2013189. https:\/\/doi.org\/10.1007\/s007020200014 (2002).","journal-title":"J. Neural Trans."},{"key":"52612_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.nbd.2004.07.006","volume":"17","author":"P Guidetti","year":"2004","unstructured":"Guidetti, P., Luthi-Carter, R. E., Augood, S. J. & Schwarcz, R. Neostriatal and cortical quinolinate levels are increased in early grade Huntington\u2019s disease. Neurobiol. Dis. 17, 455\u2013461. https:\/\/doi.org\/10.1016\/j.nbd.2004.07.006 (2004).","journal-title":"Neurobiol. Dis."},{"key":"52612_CR11","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1515\/cclm.1998.132","volume":"36","author":"F Leblhuber","year":"1998","unstructured":"Leblhuber, F. et al. Activated immune system in patients with Huntington\u2019s disease. Clin. Chem. Lab. Med. 36, 747\u2013750. https:\/\/doi.org\/10.1515\/cclm.1998.132 (1998).","journal-title":"Clin. Chem. Lab. Med."},{"key":"52612_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1158\/1541-7786.Mcr-18-0362","volume":"17","author":"LI Greene","year":"2019","unstructured":"Greene, L. I. et al. A role for tryptophan-2,3-dioxygenase in CD8 T-cell suppression and evidence of tryptophan catabolism in breast cancer patient plasma. Mol. Cancer Res. 17, 131\u2013139. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-18-0362 (2019).","journal-title":"Mol. Cancer Res."},{"key":"52612_CR13","doi-asserted-by":"publisher","first-page":"869307","DOI":"10.3389\/fimmu.2022.869307","volume":"13","author":"N Chen","year":"2022","unstructured":"Chen, N., Peng, C. & Li, D. Epigenetic underpinnings of inflammation: A key to unlock the tumor microenvironment in glioblastoma. Front. Immunol. 13, 869307. https:\/\/doi.org\/10.3389\/fimmu.2022.869307 (2022).","journal-title":"Front. Immunol."},{"key":"52612_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"CA Opitz","year":"2011","unstructured":"Opitz, C. A. et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478, 197\u2013203. https:\/\/doi.org\/10.1038\/nature10491 (2011).","journal-title":"Nature"},{"key":"52612_CR15","doi-asserted-by":"publisher","first-page":"396","DOI":"10.4161\/onci.19071","volume":"1","author":"M Platten","year":"2012","unstructured":"Platten, M., Litzenburger, U. & Wick, W. The aryl hydrocarbon receptor in tumor immunity. Oncoimmunology 1, 396\u2013397. https:\/\/doi.org\/10.4161\/onci.19071 (2012).","journal-title":"Oncoimmunology"},{"key":"52612_CR16","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.7150\/thno.60679","volume":"11","author":"V Panitz","year":"2021","unstructured":"Panitz, V. et al. Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastoma. Theranostics 11, 9217\u20139233. https:\/\/doi.org\/10.7150\/thno.60679 (2021).","journal-title":"Theranostics"},{"key":"52612_CR17","doi-asserted-by":"publisher","first-page":"716980","DOI":"10.3389\/fimmu.2021.716980","volume":"12","author":"K Skorobogatov","year":"2021","unstructured":"Skorobogatov, K. et al. Brain versus blood: A systematic review on the concordance between peripheral and central kynurenine pathway measures in psychiatric disorders. Front. Immunol. 12, 716980. https:\/\/doi.org\/10.3389\/fimmu.2021.716980 (2021).","journal-title":"Front. Immunol."},{"key":"52612_CR18","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1038\/s41467-018-04366-7","volume":"9","author":"LV Sinclair","year":"2018","unstructured":"Sinclair, L. V., Neyens, D., Ramsay, G., Taylor, P. M. & Cantrell, D. A. Single cell analysis of kynurenine and system L amino acid transport in T cells. Nat. Commun. 9, 1981. https:\/\/doi.org\/10.1038\/s41467-018-04366-7 (2018).","journal-title":"Nat. Commun."},{"issue":"Pt 1","key":"52612_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/brain\/120.1.1","volume":"120","author":"G Giovannoni","year":"1997","unstructured":"Giovannoni, G. et al. Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis. Brain J. Neurol. 120(Pt 1), 1\u201313. https:\/\/doi.org\/10.1093\/brain\/120.1.1 (1997).","journal-title":"Brain J. Neurol."},{"key":"52612_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1373\/jalm.2019.030007","volume":"5","author":"CM Stuart","year":"2020","unstructured":"Stuart, C. M. High-throughput urinary neopterin-to-creatinine ratio monitoring of systemic inflammation. J. Appl. Lab. Med. 5, 101\u2013111 (2020).","journal-title":"J. Appl. Lab. Med."},{"key":"52612_CR21","first-page":"155","volume":"2","author":"H Khorami","year":"2003","unstructured":"Khorami, H., Neyestani, T., Kadkhodaee, M. & Lotfi, J. Increased urinary neopterin: Creatinine ratio as a marker of activation of cell-mediated immunity and oxidative stress in the Iranian patients with multiple sclerosis. Iran. J. Allergy Asthma Immunol. 2, 155\u2013158 (2003).","journal-title":"Iran. J. Allergy Asthma Immunol."},{"key":"52612_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-0625.1999.tb00367.x","volume":"8","author":"F Hamerlinck","year":"1999","unstructured":"Hamerlinck, F. F. Neopterin: A review. Exp. Dermatol. 8, 167\u2013176. https:\/\/doi.org\/10.1111\/j.1600-0625.1999.tb00367.x (1999).","journal-title":"Exp. Dermatol."},{"key":"52612_CR23","doi-asserted-by":"publisher","first-page":"196432","DOI":"10.1155\/2013\/196432","volume":"2013","author":"M Eisenhut","year":"2013","unstructured":"Eisenhut, M. Neopterin in diagnosis and monitoring of infectious diseases. J Biomark 2013, 196432. https:\/\/doi.org\/10.1155\/2013\/196432 (2013).","journal-title":"J Biomark"},{"key":"52612_CR24","doi-asserted-by":"publisher","first-page":"280","DOI":"10.21037\/atm.2017.06.29","volume":"5","author":"B Melichar","year":"2017","unstructured":"Melichar, B. et al. Neopterin as a biomarker of immune response in cancer patients. Ann. Transl. Med. 5, 280 (2017).","journal-title":"Ann. Transl. Med."},{"key":"52612_CR25","doi-asserted-by":"publisher","first-page":"3850","DOI":"10.1038\/s41467-019-11719-3","volume":"10","author":"A Galstyan","year":"2019","unstructured":"Galstyan, A. et al. Blood\u2013brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy. Nat. Commun. 10, 3850. https:\/\/doi.org\/10.1038\/s41467-019-11719-3 (2019).","journal-title":"Nat. Commun."},{"key":"52612_CR26","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/ijc.34434","volume":"152","author":"S Jordaens","year":"2023","unstructured":"Jordaens, S. et al. Urine biomarkers in cancer detection: A systematic review of preanalytical parameters and applied methods. Int. J. Cancer 152, 2186\u20132205. https:\/\/doi.org\/10.1002\/ijc.34434 (2023).","journal-title":"Int. J. Cancer"},{"key":"52612_CR27","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.1158\/1078-0432.Ccr-21-1392","volume":"27","author":"L Zhai","year":"2021","unstructured":"Zhai, L. et al. Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma. Clin. Cancer Res. 27, 6514\u20136528. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-1392 (2021).","journal-title":"Clin. Cancer Res."},{"key":"52612_CR28","doi-asserted-by":"publisher","first-page":"14975","DOI":"10.1038\/s41598-024-65907-3","volume":"14","author":"A Jacquerie","year":"2024","unstructured":"Jacquerie, A. et al. Prognostic relevance of high expression of kynurenine pathway markers in glioblastoma. Sci. Rep. 14, 14975. https:\/\/doi.org\/10.1038\/s41598-024-65907-3 (2024).","journal-title":"Sci. Rep."},{"key":"52612_CR29","doi-asserted-by":"publisher","first-page":"730289","DOI":"10.3389\/fimmu.2021.730289","volume":"12","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Immunomodulatory effects of tryptophan metabolism in the glioma tumor microenvironment. Front. Immunol. 12, 730289. https:\/\/doi.org\/10.3389\/fimmu.2021.730289 (2021).","journal-title":"Front. Immunol."},{"key":"52612_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330 (2005).","journal-title":"N. Engl. J. Med."},{"key":"52612_CR31","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.talanta.2011.06.027","volume":"85","author":"L Krcmova","year":"2011","unstructured":"Krcmova, L. et al. Determination of neopterin, kynurenine, tryptophan and creatinine in human serum by high throuput HPLC. Talanta 85, 1466\u20131471. https:\/\/doi.org\/10.1016\/j.talanta.2011.06.027 (2011).","journal-title":"Talanta"},{"key":"52612_CR32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1515\/pteridines.2005.16.4.174","volume":"16","author":"M Cermanov\u00e1","year":"2005","unstructured":"Cermanov\u00e1, M. et al. Urinary neopterin and microalbuminuria in patients treated by low-density lipoprotein apheresis. Pteridines 16, 174\u2013183. https:\/\/doi.org\/10.1515\/pteridines.2005.16.4.174 (2005).","journal-title":"Pteridines"},{"key":"52612_CR33","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1515\/cclm-2023-0381","volume":"61","author":"LK Kr\u010dmov\u00e1","year":"2023","unstructured":"Kr\u010dmov\u00e1, L. K. et al. Neopterin and kynurenine in serum and urine as prognostic biomarkers in hospitalized patients with delta and omicron variant SARS-CoV-2 infection. Clin. Chem. Lab. Med. 61, 2053\u20132064. https:\/\/doi.org\/10.1515\/cclm-2023-0381 (2023).","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52612-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52612-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:57:43Z","timestamp":1792061863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-52612-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["52612"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-52612-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"32360"}}